Citations for
1CASZ1, EGFL7
The CASZ1/Egfl7 transcriptional pathway is required for RhoA expression in vascular endothelial cells.
Charpentier MS, Taylor JM, Conlon FL.
Small GTPases 4(4). [Epub ahead of print] Review. 2013
2EGFL7
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.
Johnson L, Huseni M, Smyczek T, Lima A, Yeung S, Cheng JH, Molina R, Kan D, De Mazière A, Klumperman J, Kasman I, Zhang Y, Dennis MS, Eastham-Anderson J, Jubb AM, Hwang O, Desai R, Schmidt M, Nannini MA, Barck KH, Carano RA, Forrest WF, Song Q, Chen DS, Naumovski L, Singh M, Ye W, Hegde PS.
J Clin Invest 123(9):3997-4009. doi: 10.1172/JCI67892. Epub 2013 Aug 15. 2013
3CASZ1, EGFL7
Transcriptional regulation of blood vessel formation: the role of the CASZ1/Egfl7/RhoA pathway.
Charpentier MS, Dorr KM, Conlon FL.
Cell Cycle 12(14):2165-6. No abstract available. 2013
4CASZ1, EGFL7
CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway.
Charpentier MS, Christine KS, Amin NM, Dorr KM, Kushner EJ, Bautch VL, Taylor JM, Conlon FL.
Dev Cell 25(2):132-43. doi: 10.1016/j.devcel.2013.03.003. 2013
5EGFL7
The expression of Egfl7 in human normal tissues and epithelial tumors.
Fan C, Yang LY, Wu F, Tao YM, Liu LS, Zhang JF, He YN, Tang LL, Chen GD, Guo L.
Int J Biol Markers 28(1):71-83. doi: 10.5301/JBM.2013.10568. 2013
6EGFL7
Expression of Egfl7 correlates with low-grade invasive lesions in human breast cancer.
Philippin-Lauridant G, Baranzelli MC, Samson C, Fournier C, Pinte S, Mattot V, Bonneterre J, Soncin F.
Int J Oncol 42(4):1367-75. doi: 10.3892/ijo.2013.1820. Epub 2013 Feb 8. 2013
7EGFL7
EGFL7: a unique angiogenic signaling factor in vascular development and disease.
Nichol D, Stuhlmann H.
Blood 119(6):1345-52. doi: 10.1182/blood-2011-10-322446. Epub 2011 Dec 7. Review. 2012
8ACVRL1, EGFL7
Gene expression profiling of placentae from women with early- and late-onset pre-eclampsia: down-regulation of the angiogenesis-related genes ACVRL1 and EGFL7 in early-onset disease.
Junus K, Centlow M, Wikström AK, Larsson I, Hansson SR, Olovsson M.
Mol Hum Reprod 18(3):146-55. doi: 10.1093/molehr/gar067. Epub 2011 Oct 19. 2012
9EGFL6, EGFL7
EGFL6 promotes endothelial cell migration and angiogenesis through the activation of extracellular signal-regulated kinase.
Chim SM, Qin A, Tickner J, Pavlos N, Davey T, Wang H, Guo Y, Zheng MH, Xu J.
J Biol Chem 286(25):22035-46. Epub 2011 Apr 29. 2011
10EGFL7
Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation.
Delfortrie S, Pinte S, Mattot V, Samson C, Villain G, Caetano B, Lauridant-Philippin G, Baranzelli MC, Bonneterre J, Trottein F, Faveeuw C, Soncin F.
Cancer Res 71(23):7176-86. doi: 10.1158/0008-5472.CAN-11-1301. Epub 2011 Oct 28. 2011
11EGFL7
Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells.
Badiwala MV, Tumiati LC, Joseph JM, Sheshgiri R, Ross HJ, Delgado DH, Rao V.
Circulation 122(11 Suppl):S156-61. doi: 10.1161/CIRCULATIONAHA.109.927715. 2010
12EGFL7
Epidermal growth factor-like domain 7 (EGFL7) modulates Notch signalling and affects neural stem cell renewal.
Schmidt MH, Bicker F, Nikolic I, Meister J, Babuke T, Picuric S, Müller-Esterl W, Plate KH, Dikic I.
Nat Cell Biol 11(7):873-80. Epub 2009 Jun 7. Erratum in: Nat Cell Biol. 2009 Aug;11(8):1043. 2009
13EGFL7
Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death.
Xu D, Perez RE, Ekekezie II, Navarro A, Truog WE.
Am J Physiol Lung Cell Mol Physiol 294(1):L17-23. Epub 2007 Oct 12. 2008
14EGFL7
The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation.
Parker LH, Schmidt M, Jin SW, Gray AM, Beis D, Pham T, Frantz G, Palmieri S, Hillan K, Stainier DY, De Sauvage FJ, Ye W.
Nature 428(6984):754-8. 2004